Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest

NCT04807933 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-12-10

No results posted yet for this study

Summary

Evaluation of the physiological and clinical effects of the biofeedback training with patients suffering from somatoform disorders, depending on their neurovegetative profile related to a visceral-brain decoupling.

Conditions

  • Somatoform Disorders
  • Irritable Bowel Syndrome
  • Psychogenic Non-Epileptic Seizure

Interventions

BEHAVIORAL

Heart rate variability Biofeedback [HRV-BFB]

BFB consists of a physiological recording used as a visual physiological feedback that can teach us how to control our physiology, which is naturally unconscious and uncontrollable. The BFB focused on the heart rate variability (HRV-BFB) could regulate the autonomic nervous system (vagal tone and sympathetic-parasympathetic balance) and the emotional state. The HRV BFB has received several clinical and experimental confirmations as a physiological remediation method. It is an innovative and non-pharmacological therapy frequently used to relieve stress.

Sponsors & Collaborators

  • Laboratoire de Psychologie et NeuroCognition

    collaborator OTHER
  • Laboratoire interuniversitaire de psychologie - LIP-PC2S

    collaborator UNKNOWN
  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Bruno BONAZ, Pr · University Hospital, Grenoble

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2023-07-05
Completion
2023-09-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04807933 on ClinicalTrials.gov